Hemostasis without clot formation–how platelets guard the vasculature in inflammation, infection, and malignancy

R Kaiser, R Escaig, L Nicolai - Blood, 2023 - Elsevier
Platelets are key vascular effectors in hemostasis, with activation signals leading to fast
recruitment, aggregation, and clot formation. The canonical process of hemostasis is well …

Platelet mechanosensing as key to understanding platelet function

I Schoen, M Kenny, S Patil - Current Opinion in Hematology, 2024 - journals.lww.com
New findings unravel novel mechanotransduction pathways and effector functions in
platelets, establishing mechanobiology as a pivotal component of platelet function. These …

Procoagulant platelet activation promotes venous thrombosis

R Kaiser, R Dewender, M Mulkers, J Stermann… - Blood, 2024 - ashpublications.org
Platelets are key players in cardiovascular disease, and platelet aggregation represents a
central pharmacologic target, particularly in secondary prevention. However, inhibition of …

Peripheral priming induces plastic transcriptomic and proteomic responses in circulating neutrophils required for pathogen containment

R Kaiser, C Gold, M Joppich, Q Loew, A Akhalkatsi… - Science …, 2024 - science.org
Neutrophils rapidly respond to inflammation and infection, but to which degree their
functional trajectories after mobilization from the bone marrow are shaped within the …

G12/13 signaling in asthma

EL McDuffie, RA Panettieri Jr, CP Scott - Respiratory Research, 2024 - Springer
Shortening of airway smooth muscle and bronchoconstriction are pathognomonic for
asthma. Airway shortening occurs through calcium-dependent activation of myosin light …

Clot Retraction and Its Correlation with the Function of Platelet Integrin αIIbβ3

D Gao, CW Sun, AB Woodley, J Dong - Biomedicines, 2023 - mdpi.com
Clot retraction results from retractions of platelet filopodia and fibrin fibers and requires the
functional platelet αIIbβ3 integrin. This assay is widely used to test the functions of platelets …

Comparison of long‐term outcomes between imatinib and dasatinib prophylaxis after allogeneic stem cell transplantation in patients with Philadelphia‐positive acute …

F Guan, L Yang, Y Chen, J Shi, X Song, X Lai, Y Lu… - Cancer, 2024 - Wiley Online Library
Background Although the prognosis of Philadelphia‐positive acute lymphoblastic leukemia
(Ph+ ALL) has improved with the introduction of tyrosine kinase inhibitors (TKIs) and stem …

Role of the NO-GC/cGMP signaling pathway in platelet biomechanics

A Balmes, JG Rodríguez, J Seifert, D Pinto-Quintero… - Platelets, 2024 - Taylor & Francis
Cyclic guanosine monophosphate (cGMP) is a second messenger produced by the NO-
sensitive guanylyl cyclase (NO-GC). The NO-GC/cGMP pathway in platelets has been …

Translating Senotherapeutic Interventions into the Clinic with Emerging Proteomic Technologies

AK Dey, R Banarjee, M Boroumand, DV Rutherford… - Biology, 2023 - mdpi.com
Simple Summary The accumulation of senescent cells is now widely known to be a driver of
aging and many age-related pathologies, such as neurodegeneration and type 2 diabetes …

The hemorrhage risk of dasatinib therapy

G Pontarollo, C Reinhardt - Blood, 2023 - ashpublications.org
In this issue of Blood, Kaiser et al 1 pinpoint the glycoprotein IIb (GPIIB)/Gα13/Src tyrosine
kinase (c-Src)/14-3-3ζ signaling axis as a requirement for platelet migration and shed light …